Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.28
-0.05-3.76%
Last update: Oct 9, 6:41 PM
$1.26
-0.07-5.26%
RenovoRx Inc (RNXT) Stock Price, Quote, News & History
RNXTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Other companies in RenovoRx’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
RenovoRx has a consensus price target of $7.17.
The stock price for RenovoRx (NASDAQ: RNXT) is $1.26 last updated October 9, 2026 at 6:41 PM EDT.
There are no upcoming dividends for RenovoRx.
RenovoRx does not have any upcoming earnings scheduled.
There is no upcoming split for RenovoRx.
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
